Skip to main content
. 2021 Jan 6;21:21. doi: 10.1186/s12884-020-03494-7

Table 2.

Association of GDM status and blood glucose level with infant growth measures using linear mixed effects model

Infant Growth Measures GDM (ref. = non-GDM),
β (95% CI)
Blood Glucose Level, β (95% CI)
Fasting 1 h after OGTT 2 h after OGTT
WFLZ
 Model 1 a 0.29 (0.15, 0.42) 0.14 (0.04, 0.25) 0.03 (0.00, 0.06) 0.02 (−0.02, 0.07)
 Model 2 a 0.25 (0.12, 0.38) 0.11 (0.00, 0.21) 0.00 (−0.03, 0.03) 0.02 (− 0.03, 0.06)
 Model 3 b 0.26 (0.13, 0.40) 0.12 (0.01, 0.23) 0.03 (−0.01, 0.06) 0.02 (− 0.02, 0.06)
WFAZ
 Model 1 a 0.13 (0.00, 0.26) 0.13 (0.02, 0.23) 0.11 (−0.02, 0.04) 0.02 (−0.02, 0.06)
 Model 2 a 0.09 (−0.04, 0.23) 0.09 (−0.01, 0.20) 0.00 (− 0.03, 0.04) 0.01 (− 0.03, 0.05)
 Model 3 b 0.13 (0.01, 0.26) 0.13 (0.03, 0.23) 0.02 (−0.02, 0.05) 0.03 (−0.01, 0.06)
LFAZ
 Model 1 a −0.09 (− 0.24, 0.06) 0.04 (− 0.08, 0.16) −0.01 (− 0.05, 0.03) −0.02 (− 0.07, 0.02)
 Model 2 a − 0.10 (− 0.26, 0.05) 0.03 (− 0.09, 0.15) −0.01 (− 0.05, 0.03) −0.03 (− 0.07, 0.02)
 Model 3 b − 0.06 (− 0.20, 0.08) 0.08 (− 0.04, 0.18) 0.00 (− 0.03, 0.03) −0.01 (− 0.06, 0.03)

Model 1: adjusted for the age of infants at each measurement

Model 2: Model 1 + pre-pregnancy BMI

Model 3: Model 2 + maternal age, parity, gestational age

Abbreviations: GDM gestational diabetes mellitus, CI confidence interval, OGTT oral glucose tolerance test, WFLZ weight-for-length z-score, WFAZ weight-for-age z-score, LFAZ length-for-age z-score, BMI body mass index

a: n = 945; b: n = 942 because of missing data